Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.
HIV
alcohol use
binge drinking
people with HIV
smoking
type 1 myocardial infarction
type 2 myocardial infarction
Journal
HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
08
06
2022
accepted:
19
01
2023
pmc-release:
01
06
2024
medline:
9
6
2023
pubmed:
2
3
2023
entrez:
1
3
2023
Statut:
ppublish
Résumé
People with HIV have a higher risk of myocardial infarction (MI) than the general population, with a greater proportion of type 2 MI (T2MI) due to oxygen demand-supply mismatch compared with type 1 (T1MI) resulting from atherothrombotic plaque disruption. People living with HIV report a greater prevalence of cigarette and alcohol use than do the general population. Alcohol use and smoking as risk factors for MI by type are not well studied among people living with HIV. We examined longitudinal associations between smoking and alcohol use patterns and MI by type among people living with HIV. Using longitudinal data from the Centers for AIDS Research Network of Integrated Clinical Systems cohort, we conducted time-updated Cox proportional hazards models to determine the impact of smoking and alcohol consumption on adjudicated T1MI and T2MI. Among 13 506 people living with HIV, with a median 4 years of follow-up, we observed 177 T1MI and 141 T2MI. Current smoking was associated with a 60% increase in risk of both T1MI and T2MI. In addition, every cigarette smoked per day was associated with a 4% increase in risk of T1MI, with a suggestive, but not significant, 2% increase for T2MI. Cigarette use had a greater impact on T1MI for men than for women and on T2MI for women than for men. Increasing alcohol use was associated with a lower risk of T1MI but not T2MI. Frequency of heavy episodic alcohol use was not associated with MI. Our findings reinforce the prioritization of smoking reduction, even without cessation, and cessation among people living with HIV for MI prevention and highlight the different impacts on MI type by gender.
Identifiants
pubmed: 36855253
doi: 10.1111/hiv.13466
pmc: PMC10330202
mid: NIHMS1891053
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
703-715Subventions
Organisme : NIAAA NIH HHS
ID : U01 AA020802
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIDA NIH HHS
ID : U24 DA058307
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA044112
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI067039
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020801
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : NIAAA NIH HHS
ID : K23 AA029045
Pays : United States
Organisme : NIAAA NIH HHS
ID : P01 AA029544
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020793
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG067069
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126538
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA047045
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL125027
Pays : United States
Informations de copyright
© 2023 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.
Références
Prev Med. 2018 Jun;111:231-234
pubmed: 29550303
BMJ. 2017 Mar 22;356:j909
pubmed: 28331015
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
PLoS One. 2017 May 11;12(5):e0176686
pubmed: 28493892
Curr HIV Res. 2006 Jan;4(1):97-106
pubmed: 16454715
J Am Coll Cardiol. 2017 Aug 22;70(8):913-922
pubmed: 28818200
BMC Med. 2021 Jan 12;19(1):8
pubmed: 33430840
Subst Abuse Treat Prev Policy. 2019 Nov 14;14(1):52
pubmed: 31727086
Lancet. 2015 Nov 14;386(10007):1945-1954
pubmed: 26386538
Circulation. 2014 Jul 29;130(5):390-8
pubmed: 24928682
Int J Epidemiol. 2008 Oct;37(5):948-55
pubmed: 18263650
J Cardiovasc Risk. 2002 Apr;9(2):67-76
pubmed: 12006913
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Alcohol Alcohol. 2002 Nov-Dec;37(6):591-6
pubmed: 12414553
Eur J Epidemiol. 2001;17(12):1131-7
pubmed: 12530773
Diabetes Care. 2004 Jan;27(1):184-9
pubmed: 14693987
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
BMJ. 1999 Dec 11;319(7224):1523-8
pubmed: 10591709
Tob Control. 2005 Oct;14(5):356-8
pubmed: 16183987
J Addict Med. 2016 Jan-Feb;10(1):13-9
pubmed: 26656939
Scand J Prim Health Care. 2015;33(3):153-62
pubmed: 26194171
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
Alcohol Alcohol. 2018 Jul 01;53(4):439-447
pubmed: 29546271
AIDS Behav. 2019 Jan;23(1):140-151
pubmed: 29995206
AIDS. 2021 May 1;35(6):957-970
pubmed: 33470609
J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576
pubmed: 28520615
J Geriatr Cardiol. 2016 Jan;13(1):15-22
pubmed: 26918008
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
AIDS Behav. 2015 Jan;19(1):178-85
pubmed: 24770984
Am J Epidemiol. 2014 Apr 15;179(8):996-1005
pubmed: 24618065
Epidemiology. 2015 Mar;26(2):143-50
pubmed: 25563434
J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):245-53
pubmed: 21499115
Circulation. 2005 Sep 6;112(10):1406-13
pubmed: 16129796
J Am Heart Assoc. 2019 Jul 16;8(14):e012241
pubmed: 31266386
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
N Engl J Med. 2006 Jun 8;354(23):2473-83
pubmed: 16760447
J Am Coll Cardiol. 2021 Feb 23;77(7):848-857
pubmed: 33602466
Curr Pharm Des. 2009;15(10):1038-53
pubmed: 19355946
Alcohol Clin Exp Res. 2005 May;29(5):844-54
pubmed: 15897730
Heart. 2021 Sep;107(18):1444-1445
pubmed: 34193466
Curr HIV Res. 2007 Jan;5(1):109-18
pubmed: 17266562
BMJ Open. 2019 Sep 24;9(9):e025874
pubmed: 31551371
Biomed Pharmacother. 1999 Oct;53(9):417-23
pubmed: 10554677
JAMA Cardiol. 2017 Mar 1;2(3):260-267
pubmed: 28052152
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
QJM. 2015 Jul;108(7):539-48
pubmed: 25519235
Subst Use Misuse. 2006;41(10-12):1465-507
pubmed: 17002990
J Am Coll Cardiol. 2019 Apr 16;73(14):1846-1860
pubmed: 30975302
Circulation. 2016 Mar 8;133(10):979-87
pubmed: 26936862
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):224-230
pubmed: 30865179
BMC Med. 2019 Jul 3;17(1):128
pubmed: 31266500
Heart. 2021 Sep;107(18):1480-1486
pubmed: 33879450
Cardiovasc Diagn Ther. 2017 Aug;7(4):348-358
pubmed: 28890871
Am J Med. 2018 Oct;131(10):1209-1219
pubmed: 29753793
J Am Heart Assoc. 2020 Jan 7;9(1):e013744
pubmed: 31880980
AIDS Behav. 2018 Sep;22(9):2868-2876
pubmed: 29680935
Am Heart J. 1991 Aug;122(2):438-47
pubmed: 1858623
BMJ. 1998 Apr 4;316(7137):1043-7
pubmed: 9552903
Eur J Epidemiol. 2013 Aug;28(8):659-67
pubmed: 23443581
J Intern Med. 2016 Apr;279(4):365-75
pubmed: 26365927
Eur J Public Health. 2012 Dec;22(6):825-30
pubmed: 21398379
Tob Control. 2004 Sep;13(3):244-50
pubmed: 15333879
Prog Cardiovasc Dis. 2003 Jul-Aug;46(1):91-111
pubmed: 12920702
Epidemiology. 2004 Nov;15(6):767-9
pubmed: 15475728
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):208-212
pubmed: 33433123
Curr HIV/AIDS Rep. 2015 Dec;12(4):421-36
pubmed: 26412084
JAMA. 2002 May 15;287(19):2559-62
pubmed: 12020337